J.P. Obrecht
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 3
- Immunology 10
- Immune Cell Function and Interaction 5
- Immune cells in cancer 4
- Immune Response and Inflammation 4
- Co-authors
- R. Obrist (10 shared papers)W. F. Jungi (5 shared papers)Christian Ludwig (5 shared papers)R. Landmann (4 shared papers)F. Cavalli (4 shared papers)M. Castiglione (3 shared papers)F. Harder (3 shared papers)Beat Thürlimann (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Anesthesiology (1 paper)Molecular Immunology (1 paper)Acta Haematologica (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- SwitzerlandItalyGermany
In The Last Decade
J.P. Obrecht
31 papers receiving 424 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 140
- Oncology 144
- Immunology 105
- Pathology and Forensic Medicine 56
- Hematology 27
Countries citing papers authored by J.P. Obrecht
This map shows the geographic impact of J.P. Obrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Obrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Obrecht more than expected).
Fields of papers citing papers by J.P. Obrecht
This network shows the impact of papers produced by J.P. Obrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Obrecht. The network helps show where J.P. Obrecht may publish in the future.
Co-authors
The 25 scholars most cited alongside J.P. Obrecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 125 | |
| 2 | 1991 | 67 | |
| 3 | 1983 | 54 | |
| 4 | 1991 | 42 | |
| 5 | 1982 | 26 | |
| 6 | Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide. | 1984 | 24 |
| 7 | 1974 | 16 | |
| 8 | 1993 | 15 | |
| 9 | 1990 | 13 | |
| 10 | 1992 | 11 | |
| 11 | 1997 | 9 | |
| 12 | 1990 | 8 | |
| 13 | 1988 | 7 | |
| 14 | 2008 | 5 | |
| 15 | 1982 | 4 | |
| 16 | 1991 | 4 | |
| 17 | 1980 | 3 | |
| 18 | 1981 | 3 | |
| 19 | 1998 | 3 | |
| 20 | 2009 | 2 |
About J.P. Obrecht
J.P. Obrecht is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 37 papers that have together received 456 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (5 papers), Immune Cell Function and Interaction (5 papers), Immune cells in cancer (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Immune Response and Inflammation (4 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (140 citations), Oncology (144 citations), Immunology (105 citations), Pathology and Forensic Medicine (56 citations) and Hematology (27 citations). J.P. Obrecht has collaborated with scholars based in Switzerland, Italy and Germany. Frequent co-authors include R. Obrist, W. F. Jungi, Christian Ludwig, R. Landmann, F. Cavalli, M. Castiglione, F. Harder, Beat Thürlimann, M. Bacchi and Aron Goldhirsch. Their work appears in journals such as Journal of Clinical Oncology, Anesthesiology, Molecular Immunology, Acta Haematologica and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.